Weaning strategy with inhaled nitric oxide treatment in persistent pulmonary hypertension of the newborn

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 76, Issue 2, 1997, Pages

  Aly, Hany ^a   Sahni, Rakesh ^a   Wung, Jen Tien ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Department of Anesthesia ^*

Author keywords

ECMO; Inhaled nitric oxide; Weaning

Indexed keywords

NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; LUNG VASCULAR RESISTANCE; MALE; NEWBORN; OXYGEN SATURATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT PLANNING; VASCULAR SMOOTH MUSCLE; WEANING;

EID: 0031428207     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.76.2.F118     Document Type: Article

References (32)

1. Davidson D, Eldemerdash A. Endothelium-derived relaxing factor: Presence in pulmonary and systemic arteries of the newborn guinea pig. Pediatr Res 1990;27:128-32.
2. Davidson D, Eldemerdash A. Endothelium-derived relaxing factor: evidence that it regulates pulmonary vascular resistance in the isolated newborn guinea pig lung. Pediatr Res 1991;29:538-42.
3. Abman SH, Chatfield BA, Hall SL, Mc Murtry IF. Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth. Am J Physiol 1990;259:H1921-7.
4. Shaul PW, Farrar MA, Zellers TM. Oxygen Modulates endothelium-derived relaxing factor production in fetal pulmonary arteries. Am J Physiol 1992;262:H355-64.
5. Tiktinsky MH, Cummings JJ, Morin III FC. Acetyl choline increases pulmonary blood flow in intact fetuses via endothelium-dependent vasodilatation. Am J Physiol 1992;262:H406-11.
6. Kinsella JP, Neish SR, Shaffer E, Abman SH. Low dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:819-20.
7. Roberts JD Jr, Chen T-Y, Kawai N, Wain J, Dupuy P, Shimouchi A, et al. Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ Res 1993;72:246-54.
8. Pison U, Lopez FA, Heidelmeyer CF, Rossaint R, Falke K. Inhaled nitric oxide selectively reverses hypoxic pulmonary vasoconstriction without impairing pulmonary gas exchange. J Appl Physiol 1993;74:1287-92.
9. Roberts JD, Polaner DM, Lang P, Zapol WM. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992;340:818-9.
10. Stephens RJ, Freeman G, Evans MJ, Park M. Early response of lungs to low levels of nitrogen dioxide. Arch Environ Health 1972;24:160-79.
11. Hugod C. Effect of exposure to 43 ppm nitric oxide and 3.6 nitrogen dioxide on rabbit lung, Int Arch Occup Environ Health 1979;42:156-67.
12. Hugod C. Ultrastructural changes of the rabbit lung after 5 ppm nitric oxide exposure. Arch Environ Health 1977:13-6.
13. 3. Toxicol Appl Pharmacol 1988;96:451-64.
14. Dowell AR, Kilburn KH, Pratt PC. Short term exposure to nitrogen dioxide. Effects on pulmonary ultrastructure, compliance and the syrfactant system. Arch Intern Med 1971; 128:74-80.
15. Oda H, Kusumoto S, Nakajimia T. Nitrosyl-hemoglobin formation in the blood of animals exposed to nitric oxide. Arch Environ Health 1975;30:453-65.
16. Chiodi H, Mohler JG. Effects of exposure of blood hemoglobin to nitric oxide. Environ Res 1985;37:355-63.
17. Goldman AP, Tasker RC, Haworth SG, Sigston PE, Macrae DJ. Four patterns of response to inhaled nitric oxide for persistent pulmonary hypertension of the newborn. Pediatrics 1996;98:706-13.
18. Kinsella JP, Niesh SR, Ivy DD, Shaffer E, Abman SH. Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low dose inhaled nitric oxide. J Pediatr. 1993;123:103-8.
19. Frostell C, Fratacci MD, Wain JC, Jones R, Zapol WM. Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991;83:2038-47.
20. Petros A. Down-regulation of endogenous nitric oxide production after prolonged administration. Lancet 1994;344:191.
21. Miller O, Tang S, Keech A, Celermajer D. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide. Lancet 1995;346:51-2.
22. Short BL. Clinical management of the neonatal ECMO patient. In: Arensman R, Cornish D, eds. Extra -corporeal Life Support. Oxford: Blackwell Scientific, 1993:195-206.
23. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
24. Gustafsson LE, Leone AM, Persso MG. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991; 181: 852-7.
25. Fratacci MD, Frostell CG, Chen TY, Wain Jc Jr, Robinson DR, Zapol WM. Inhaled nitric oxide: A selective pulmonary vasodilator of heparin-protamine vasoconstriction in the sheep. Anesthesiol 1991;75:990-9.
26. Ravichandran LV, Johns RA, and Rengasamy A. Direct and reversible inhibition of endothelial nitric oxide synthase by nitric oxide. Am J Physiol 1995;268:H2221-3.
27. Dollberg S, Warner BW, Myatt L. Urinary nitrite and nitrate concentrations in patients with idiopathic persistent pulmonary hypertension of the newborn and effect of extracorporeal membrane oxygenation. Pediatr Res 1995;37:31-4.
28. Rapoport RM, Murad F. Agonist-induced endothelium-dependent relaxation in rat thoracic aorta may be mediated through CGMP. Circ Res 1983;52:352-7.
29. Griffith TM, Edwards DH, Lewis MJ, Henderson AH. Evidence that cyclic guanosine monophosphate (CGMP) mediates endothelium-dependent relaxation. Eur J Pharmacol 1985;112:195-202.
30. MacLeod KM, Ng DDW, Harris KH. Evidence that CGMP is the mediator of endothelium-dependent inhibition of contractile responses of rat arteries to adrenoceptor stimulation. Mol Pharmacol 1987;32:59-64.
31. Ichinose F, Adrie C, Hurford WE, and Zapol WM. Prolonged pulmonary vasodilator action of inhaled nitric oxide by zaprinast in awake lambs. J Appl Physiol 1995;78:1288-95.
32. Fineman JR, Heymann MA, Soifer SJ. N-omega-nitro-Larginine attenuates endothelium dependent pulmonary vasodilatation in lambs. Am J Physiol 1991;260: H1299-306.